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This work presents a spatial-component (SC) based approach to aid the diagnosis of
Alzheimer’s disease (AD) using magnetic resonance images. In this approach, the whole
brain image is subdivided in regions or spatial components, and a Bayesian network
is used to model the dependencies between affected regions of AD. The structure of
relations between affected regions allows to detect neurodegeneration with an estimated
performance of 88% on more than 400 subjects and predict neurodegeneration with
80% accuracy, supporting the conclusion that modeling the dependencies between
components increases the recognition of different patterns of brain degeneration in AD.
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1. INTRODUCTION
Alzheimer’s disease (AD) is the most common cause of demen-
tia. The diagnosis of AD is presently based on the presence, in
sufficient number, of amyloid plaques and neurofibrillary tan-
gles in cortical brain areas at autopsy. AD has presently no cure,
but accurate and non-invasive diagnosis methods are of funda-
mental importance for increasing benefits from treatments and
participate in drug trials.
Since the development of brain imaging techniques, a promis-
ing research field has emerged that complements clinical diagno-
sis in a non-invasive way. Several imaging biomarkers have been
studied to characterize AD, as regional cerebral blood flow in
SPECT images, and glucose consume or amyloid plaques accu-
mulation in PET imaging. Magnetic resonance imaging (MRI) is
a non-invasive technique that provides in vivo information about
brain structures, encoded in high dimensional data. The struc-
tural information of MRI images has been extensively studied for
the diagnosis and neurodegeneration prediction of AD, following
a vast variety of approaches, including voxel-based morphome-
try (Chetelat et al., 2002), measures of cortical thickness (Lerch
et al., 2008; Eskildsen et al., 2013), or volume measures of specific
regions (Davies et al., 2002; Shen et al., 2012). Group compar-
isons of MRI data, based on statistical techniques, have revealed
that several brain regions present deviations from normality in
patients with AD, mainly the hippocampus and cortical areas in
the temporal, frontal and parietal lobes (Kaye et al., 1997; Killiany
et al., 2000). The use of functional MRI (fMRI) imaging for AD
has provided further insight into AD characteristics, showing that
important relations of connectivity exist between AD affected
regions (Kim et al., 2008; Burge et al., 2009). These findings have
been proven to be important in the prognosis of AD and the pre-
diction of decline in mild cognitive impairment (MCI) subjects
(Greicius et al., 2004). With the advance of machine learning,
computer aided diagnosis (CAD) systems have been successfully
developed to assist in individual AD diagnosis and neurodegener-
ation prediction. To this aim, automatedMRI-based CAD systems
using classification of voxel-based segmented tissues have been
proposed (Fan et al., 2008; Kloppel et al., 2008), (see Cuingnet
et al., 2011 for a comparative study). An inherent limitation of
these methods is that information of spatially separated brain
regions is considered as independent, and the effect on classifi-
cation of information dependencies between AD affected regions
are not modeled.
From the statistical pattern-recognition perspective, Bayesian
networks are powerful tools for inference that allow for rep-
resentations of complex relations between dependent features
(Friedman et al., 1997). Moreover, modeling these dependencies
can increase the classification capabilities, if compared to naive
Bayes classification (Cheng and Greiner, 2001). These techniques
have been applied in the context of fMRI analysis (Zheng and
Rajapakse, 2006; Wu et al., 2011), providing further understand-
ing of complex brain activities. If intended for classification, some
alternative modeling is required, as Spatial component (SC) anal-
ysis (Gorriz et al., 2008; Illan et al., 2011). In SC, the problem
of classification is divided into several independent classification
problems by parceling the data of a sample into subdivisions or
components and then merging the results together with some
aggregation technique. The original motivation to factorize brain
images into several smaller pieces is the search of the relevant
regions for classification. But simultaneously, the small sample
size problem in very high dimensional feature spaces may be tack-
led by means of a feature dimension reduction. And moreover,
it translates the information encoded in MRI images into local
features specially designed for classification, so that a Bayesian
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network approach can be used to produce a final classification
decision on each subject.
The pattern of the AD affection is complex, usually involving
more than a single brain region. This work focus on modeling the
dependencies between affected brain regions for effective diag-
nosis of AD and early manifestations. We try to model them
by performing a Bayesian network learning approach upon the
results of classification on regions that are found to be affected
by AD. With the use of machine learning techniques, classifiers
are able to learn the difference between AD and normal controls
from the tissue information on regions. Segmentation methods
are used to quantify the probability each voxel to belong to a dif-
ferent brain tissue, and this information is agglutinated in regions,
as defined by an anatomical atlas. Extra information concerning
AD pathology can be obtained by learning the network structure
of dependencies between classification results on each component
or region. Once the structure is obtained, the network can be used
for inference.
2. MATERIAL AND METHODS
The build up of the proposed CAD system is divided into
three stages: (i) Image pre-processing; (ii) Learning; and (iii)
Testing. The first stage is designed for feature extraction. The
VBM8 software (Ashburner and Friston, 2000) is used to segment
the different brain tissues, followed by a normalization pro-
cedure. The ICBM atlas (http://www.loni.usc.edu/atlases/Atlas_
Detail.php?atlas_id=5) is used to define the subdivision of spa-
tial components according to anatomical labeled areas. Secondly,
the tissue probability on each region is used as feature vectors,
and the differences between classes are learned by a support vector
machine (SVM, Vapnik, 1998). The binary output define the val-
ues of the nodes in a Bayesian network, whose structure is learned
following a Markov chain Monte Carlo search on a training sam-
ple assuming fully observed data and a Bayesian score. Once the
topology is fixed, a maximum likelihood algorithm estimates the
values of the network parameters, and the network is finally used
for inference. The results of this procedure are compared to other
standards in machine learning for CAD. Other aggregation tech-
niques are proposed and compared, as majority voting. Finally,
the generalization capability of each proposed CAD is estimated
and compared, focusing on mild cognitive impairment subjects
with a diagnosis of conversion to AD, to evaluate the diagnosis
capability of the methods in early stages of the disease.
2.1. DATASET
Data used in the preparation of this article was obtained from
the (ADNI) database (http://adni.loni.usc.edu/). The ADNI was
launched in 2003 by the National Institute on Aging (NIA), the
National Institute of Biomedical Imaging and Bioengineering
(NIBIB), the Food and Drug Administration (FDA), private
pharmaceutical companies and non-profit organizations, as a 60
million, 5-year public-private partnership. The primary goal of
ADNI has been to test whether serial MRI, positron emission
tomography (PET), other biological markers, and clinical and
neuropsychological assessment can be combined to measure the
progression of MCI, and early AD. Determining sensitive and
specific markers of very early AD progression is intended to aid
researchers and clinicians to develop new treatments, as well as
reduce the time and cost of clinical trials.
The Principal Investigator of this initiative is Michael W.
Weiner, MD, VAMedical Center and University of California, San
Francisco. ADNI is the result of efforts of many co-investigators
from a broad range of academic institutions and private corpora-
tions, and subjects have been recruited from over 50 sites across
the U.S. and Canada. The initial goal of ADNI was to recruit
800 adults, ages 55–90, to participate in the research: approxi-
mately 200 cognitively normal older individuals to be followed for
3 years, 400 people with MCI to be followed for 3 years and 200
people with early AD to be followed for 2 years. For up-to-date
information, see www.adni-info.org.
In this article, only the data from T1-weighted MR images was
considered. The participants were separated into two different
classes:
• Normal. Control subjects. Clinical Dementia Rating (CDR) of
zero. They were non-depressed, non-MCI and non-demented.
• AD. CDR of 0.5 or 1, met NINCDS/ADRDA criteria for prob-
able AD .
Table 1 shows the demographic details of the subjects who com-
pose the dataset used in this work. Information concerning the
conversion from MCI to AD is taken from clinical data avail-
able from ADNI. Those patients whose clinical diagnosis suffer
multiple conversions and reversions are considered as not reliably
labeled and discarded from the MCI-converters cohort.
2.2. IMAGE PRE-PROCESSING AND SEGMENTATION
The pre-processing of the images starts with the registration
step. It is carried out with the diffeomorphic anatomical regis-
tration through exponentiated lie algebra (DARTEL, Ashburner,
2007), which belongs to the VBM8 toolbox within the SPM
package (http://dbm.neuro.uni-jena.de/vbm/). The precise inter-
subject alignment of DARTEL is followed by the segmentation
algorithm of SPM (Ashburner and Friston, 2005). The SPM seg-
mentation algorithm models the intensity value distribution of
the T1-weighted MRI and takes voxel location into considera-
tion via a tissue probability map. The images are segmented into
three different tissues; gray matter (GM), white matter (WM) and
cerebro-spinoid fluid (CSF), producing a set of images with dif-
ferent probability values for GM, WM, or CSF at a given voxel
and a cubic resolution of 1.5 mm per voxel. Neither smoothing
nor dimension reduction was applied.
Table 1 | Subject Demographics.
Sex M/F Mean Age/Std. Mean MMSE/Std.
NC 229 157/72 75.81/4.93 29.06/1.08
MCI-c 110 70/40 76.39/6.96 26.68/2.16
AD 188 123/65 75.33/7.17 22.84/2.91
NC, Normal Controls; MCI-c, Mild Cognitive Impairment-converters; AD,
Alzheimer’s Disease.
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2.3. SPATIAL COMPONENTS AS BAYESIAN NETWORK NODES
The information encoded by MRI images are 3D representations
of volume V ⊂ R3. An image factorization consists of a division
of the whole brain image into smaller subvolumes or components,
in order to perform the classification task over each component.
Explicitly, let the brain image database be N 3-D intensity arrays
Ii(xj), which denote the voxel intensity at the points xj ∈ V for the
brain image patient i = 1, . . . ,N. The voxel positions xj form a
cubic lattice and the intensity distribution is discretized inside V ,
analogous to 2D image pixel sampling. Let the set C = {xi : xi ∈
C ⊂ V} define a subvolume of V . If the volume V is subdivided
into M subvolumes C1,C2, . . . ,CM , also the whole brain image
Ii(V) may be decomposed into the same number of subsets or
components Ii(C1), Ii(C2), . . . , Ii(CM)
A labeled template is used to define the coordinates of each
anatomical region recognized here as spatial components. The
ICBM (International Consortium for Brain Mapping) high-
resolution single subject template is used to this aim, which is
aligned in the MNI space (Mazziotta et al., 1995). Each com-
ponent Ii(Cm) selects an anatomical region of the brain image
defined in the atlas by means of a set of voxels. The voxel
intensities contained in that component are concatenated to a
vector,
x = (I(x1), I(x2), . . . , I(xS)) ∈ RS (1)
being S the total number of voxels in that component. Each vector
is labeled with y ∈ ±1, being −1 in case the patient is NORMAL,
and+1 in case the patient is AD. These labeled vectors are used as
feature vectors for growing M SVM classifiers. Thus, the classifi-
cation task is achieved considering each component individually,
provided that the SVM ensemble is aggregated to make a final
collective decision.
2.3.1. Background on support vector machines
SVM separate a given set of binary labeled training data with a
hyperplane that is maximally distant from the two classes (known
as the maximal margin hyper-plane). The objective is to build a
function f : RS −→ {±1} using the training data from (1), con-
sisting of a size l subset of S-dimensional patterns xi and class
labels yi:
(x1, y1), (x2, y2), . . . , (xl, yl) ∈
(
R
S × {±1}) , (2)
so that f will correctly classify new examples (x′, y).
Linear discriminant functions define decision hypersurfaces or
hyperplanes in a multidimensional feature space, that is:
g(x) = wTx + w0 = 0, (3)
where w is known as the weight vector and w0 as the threshold.
The weight vector w is orthogonal to the decision hyperplane and
the margin is inversely proportional to its norm. Therefore, the
optimization task consists of finding the unknown parameterswk,
k = 1, . . . , S by minimizing the norm of the vector w subject to
some linear constraints defining the class belongings, that is:
argmin
w,w0
max
α≥0
{
1
2
‖w‖2 −
2∑
i= 1
αi[yi(w · xi − b) − 1]
}
(4)
where αi are some Lagrange multipliers in case of linear sep-
arable training data xi. The method can be extended to not
separable training data by introducing the soft margin concept
(Vapnik, 1998). Once the parameters w defining the hyperplane
are obtained, the sign of the distance from the test sample to the
hyperplane, that is, sign(g(x)), generates the decision rule.
The outcome of this decision function g is defined on them-th
component of the subject i, as:
g
(
x(i)m
)
≡ z(i)m ∈ ±1 (5)
where the feature vector x(i)m is defined in (1). Therefore,M SVMs
must be trained in order to fix the parameters of the classifier g
on each component. Once the SVM is trained, the set of binary
outcomes will serve us to define a new decision function based on
Bayesian networks. The result is to be compared with the com-
mon approach in SC, where individual votes are pasted together
to grow a collective decision function by a pasting-votes technique
(Breiman, 1999; Illan et al., 2011):
F(z(i)) =
M∑
m= 1
z(i)m (6)
It is an unweighed sum of votes that each component casts, classi-
fying the subject i as normal if F(z(i)) > 0, and as AD if F(z(i)) <
0. Majority voting is a simple and robust method of aggregation
for the problem of SVM ensemble aggregation (Kim et al., 2003).
2.3.2. Bayesian networks
Formally, a Bayesian network for a set of labeled random vari-
ables {Z,Y} is a pair G and θ . The first component, G, is a directed
acyclic graph with nodes corresponding to the the random vari-
ables. The graph G encodes the dependence relations between
variables, represented by edges. The second component of the
pair, namely θ , represents the set of parameters that quantifies the
conditional probability distribution in the network. A Bayesian
network B defines a unique joint probability distribution over U
given by:
p(z1, . . . , zM
∣∣ y) = M∏
m= 1
p
(
zm
∣∣ Pazm , y) =
M∏
m= 1
θzm | Pazm (7)
where Pazm denotes the set of parents of zm in B. When the topol-
ogy of the graph G is unknown, a set of training data can be
used to learn the structure. The common approach is to intro-
duce a scoring function that evaluates each network in the space
of all possible structures and returns either the best one or a sam-
ple of the best models according to this function. In general, an
exhaustive search in this space is Np-hard (Chickering, 1996), so
other efficient algorithms have been proposed. We used here the
Metropolis-Hastings (MH) algorithm, an Monte Carlo Markov
Chain (MCMC) algorithm, to search the space of graphs to find
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the optimal structure of the network, and the Bayesian informa-
tion criterion as the score function to find the optimal model
(Heckerman et al., 1995).
Once the network structure is learned, amaximum a posteriori
scheme is used to learn the parameters of the model, assuming
that all the variables are fully observed.
When all the parameters are fixed, the network can be used
for inference. If used as a classifier, B encodes a distribution
P(z1, . . . , zM, y) so that, given a set of features z1, . . . zM , the
classifier returns the label y that maximizes the posterior prob-
ability P(y
∣∣z1, . . . , zM), which is trivially derived from Equation
(7) using the definition of conditional probability and the chain
rule.
2.3.3. Evaluation
The classification performance of our approach is tested in
three steps: training, cross-validation and test. Cross validation is
achieved by means of the leave-one-out method, a technique that
iteratively holds out a subject for test, while training the classifier
with the remaining subjects, so that each subject is left out once.
Three parameters that measure the performance of the classifica-
tion task are: the Accuracy, the Specificity and the Sensitivity. The
definitions are:
Accuracy = Tp + Tn
Tp + Tn + Fp + Fn
Sensitivity = Tp
Tp + Fn
Specificity = Tn
Tn + Fp
where Tp, Tn, Fp, and Fn denote true positives, true negatives,
false positives, and false negatives, respectively.
3. RESULTS
The performed experiments start with separating the data into
train, test and validation sets. MCI patients are excluded from
the modeling cohort and all of them are considered for valida-
tion. Therefore, a subgroup of approximately one third of the NC
and AD subjects is hold out for validation, and the remaining two
thirds are used for train and test phase.
All the images where segmented into GM, WM, and CSF tis-
sue maps aligned in the standard MNI space, allowing for voxel
to voxel comparisons with the ICBM altas. The ICBM atlas con-
tains information of 48 brain structures, including WM and CSF
tissues. Two possible models are then analyzed depending on
the tissue information considered for the component definition:
WM or GM. CSF is excluded because it is expected to play an
unimportant role.
The limited number of available samples determine the cross
validation approach in the train-test phase. A leave-one-out cross
validation scheme is used to train the classifier of each compo-
nent, and to estimate its classification performance. Two different
classifiers are used to study the classifier influence in the model:
SVM and naive Bayes. Figures 1, 2 show the results obtained with
SVM classification and Naive Bayes respectively.
In the cross-validation step, a 48-dimensional vector of binary
values for each image is generated, z = {z1, . . . , z48, y}, with zi ∈
±1 and y the class variable. The information contained in the
image is reduced to the class assimilated on each component,
which serves to learn the Bayesian network structure that relates
the dependencies between components. In order to be used for
inference, we set the root node of the network as the class node,
that is y = ∅, and each attribute contains the class variable as
its parent (see Figure 4). If all components are included in the
analysis, there are 248 values of the conditional probability table
for each image, without considering any relation between compo-
nents, and the number of possible graphs is super-exponential in
the number of nodes. In order tomake the calculations affordable,
FIGURE 1 | Training accuracy of the atlas-defined brain regions by the SVM classifiers ensemble. Axial slices.
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FIGURE 2 | Training accuracy of the atlas-defined brain regions by the Naive Bayes classifiers ensemble. Axial slices.
FIGURE 3 | Convergence of the accepted ratio of the Metropolis-Hasting
algorithm for 6 node network.
a criteria to reduce the number of interacting components is nec-
essary. A reasonable choice lies in the balance between selecting
a significant amount of relevant regions for AD diagnosis while
keeping the number of nodes small to make the acceptance ratio
of the MCMC algorithm converge (see Figure 3).
For selecting components, we incorporate the knowledge
developed in previous works. The criteria to select components
is taken from the literature, and those regions found to play an
important role in AD detection are considered, as the parahip-
pocampal gyrus, lingual gyrus, hippocampus, frontal lobe, pre-
central gyrus, or the temporal lobe (Convit et al., 2000; Killiany
et al., 2000; Dickerson et al., 2001; Chetelat et al., 2002). This
optimum value for the number of components turns out to be
FIGURE 4 | Topology of the network learned from with maximal BIC
score and 6 nodes.
below 10 nodes, in concordance with other works (Wu et al.,
2011), guaranteeing convergence. Figure 5 shows the effect of
varying the number of components included to define the net-
work compared to majority voting approach of SC. Figure 3
shows the convergence of the search in the space of all graphs
with the Metropolis-Hastings algorithm to a local minimum, and
Figure 4 shows the structure obtained for amaximum of the score
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FIGURE 5 | Recognition rates of AD vs. NC varying the number of
components selected from the atlas and comparing the Bayesian
Network (BN) approach and the Spatial Component (SC) using voting
on different segmented tissues.
Table 2 | Estimated performance parameters for generalization.
Set Bayesian Network Voting
GM% WM% GM% WM%
AD vs. NC Accuracy 88.00 80.80 76.80 76.80
Sensitivity 92.59 81.67 85.92 90.77
Specificity 84.51 80.00 64.81 61.67
MCI-c vs. NC Accuracy 80.11 76.57 77.35 75.43
Sensitivity 77.27 74.55 72.73 72.73
Specificity 84.51 80.00 84.51 80.00
function. The software package, Bayes Net Toolbox, written by
Murphy (2004) was used for structure learning.
The conditional probability distribution (CPD) that fixes the
Bayesian-network parameters is learned from the data, provided
that some initialization is drawn from a binomial distribution.
Informative priors are not required as the data is assumed to be
fully observed. In the validation stage, the CPD parameters are
used for inference.
The generalization capability of the presented CAD is esti-
mated over the validation set. The validation is performed in two
stages, one considering NC vs. AD patients, and other one consid-
ering NC vs. MCI-converters. Also, the two possible segmented
tissues are analyzed: GM and WM. Performance parameters are
calculated, as accuracy, sensibility, specificity and the obtained
results are compared to other published methods. The results are
summarized in Table 2.
4. DISCUSSION
In this paper we have proposed successful model of dependen-
cies between brain regions for CAD of AD. Remarkably, it shows
that previously reported findings of affected brain regions in AD
and their relations can be described through a Bayesian network.
Considering these relations, the generalization of the CAD sys-
tem is estimated to be greater than other non-network based
approaches, as SC analysis with majority voting aggregation. If
compared to other automatic methods using the same database
and a comparable number of subjects, the best results obtained
with GM tissues are comparable to the best reported ones in
NC vs. AD, and superior in the prediction of MCI decline. In
Cuingnet et al. (2011), the same database and 162 CN and 137 AD
images where used to compare 28 different methods for AD diag-
nosis. The best reported results from 28 methods reach sensitivity
81% and specificity 95%, comparable to results in Table 2. These
results support the idea that the robustness of the automatic
diagnosis systems for AD depends on the ability to recognize dif-
ferent presentations of MRI structural anomalies. Moreover, it is
straightforward to include in the bayesian network results from
classification of regions in other imaging modalities as PIB PET
or even neuropsicological tests.
SVM is the optimal classifier if compared to naive Bayes classi-
fication, as can be seen from Figures 1, 2. Since the components
contain tousends of voxels, a linear kernel SVM can effectively
deal with classification problems with low number of samples
in high dimensional feature spaces (Vapnik, 1998). Furthermore,
GM tissues provide more compelling classification results (see
Table 2) as they are expected to capture better the gray matter loss
in AD affected patients.
A crucial step in the processing of MRI data is the segmen-
tation of tissues. The framework adopted in this work integrates
tissue classification and image registration, as it is required for
comparisons with atlases. The model is based on a mixture
of Gaussians and is extended to incorporate a smooth inten-
sity variation and nonlinear registration with tissue probability
maps (Ashburner, 2007). However, it is expected that AD affected
patients will develop some degree of atrophy on determined brain
regions. This fact would decrease the segmentation accuracy. This
problem is usually solved by providing AD tissue probability
maps. From the CAD perspective, introducing class-discriminant
knowledge in the processing of the data is not compatible with its
goal of classifying new unknown samples. Therefore, some degree
of inaccuracy on the segmentation of AD patients is assumed.
The present work is strongly limited by the number of brain
regions considered in the Bayesian network and the sample size.
It would be desirable to derive the model of dependencies from
the whole brain, without introducing any ad-hoc selection, but
it has been shown to be impractical. A limitation on the num-
ber of brain regions fulfill the requirements to obtain the CAD
goal, but some tangential questions may arise. One of them is
the question whether a network of dependencies between not
registered regions plays an important role in early stages of AD,
weakened as the disease progress and translated into the com-
monly reported ones. Moreover, it might be possible that brain
regions that have never been reported to be related to AD, play an
important role in the network of dependencies. These questions
deserve special attention, and can be important to understand the
disease progress. However, in the light of the presented results, it
seems unlikely to be the case. From Figure 5, it is deduced that
the performance of the bayesian network approach is stable vs.
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the variation of the component number in contrast with voting
approach. It is interesting to stress that the regions involved in
the network are not the most accurate, as can be seen in Figure 1.
While there is still a margin to improve classification results in
the NC vs. MCI-c case, it would be expected that involving more
regions in the network would not increase the recognition rates.
The fact that ADNI database is clinically labeled introduces an
unavoidable error (Jobst et al., 1998). This error comes from the
intrinsic limitations of the clinical assessment, and the general-
ization of the classifier must be interpreted from this perspective.
Taking this fact into account, it can be said that the effective per-
formance of the SC-based CAD denotes an accurate modeling of
the dependencies between most relevant brain regions.
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